Range Low Price High Price Comment
30 days $15.12 $18.49 Thursday, 28th Mar 2024 VRNA stock ended at $16.09. This is 2.48% less than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 5.85% from a day low at $15.80 to a day high of $16.73.
90 days $15.12 $20.67
52 weeks $11.83 $23.81

Historical Verona Pharma plc prices

Date Open High Low Close Volume
2024-02-22 $16.92 $17.22 $16.43 $16.80 452 365
2024-02-21 $17.11 $17.60 $16.42 $16.59 340 344
2024-02-20 $17.23 $17.58 $16.85 $17.00 342 707
2024-02-16 $16.75 $17.22 $16.57 $17.20 439 932
2024-02-15 $17.57 $17.60 $16.63 $16.75 934 159
2024-02-14 $17.32 $17.67 $16.98 $17.45 525 828
2024-02-13 $17.00 $17.71 $16.80 $16.96 570 147
2024-02-12 $17.00 $17.39 $17.00 $17.20 401 086
2024-02-09 $16.48 $17.08 $16.39 $17.01 468 704
2024-02-08 $16.26 $16.51 $15.55 $16.28 568 342
2024-02-07 $17.20 $17.23 $16.30 $16.34 528 038
2024-02-06 $17.44 $18.07 $17.00 $17.19 541 858
2024-02-05 $18.06 $18.06 $17.46 $17.57 302 390
2024-02-02 $18.39 $18.39 $17.37 $18.31 453 500
2024-02-01 $18.80 $19.10 $18.47 $18.52 328 548
2024-01-31 $18.41 $19.27 $18.35 $18.35 404 561
2024-01-30 $19.09 $19.09 $18.22 $18.40 434 563
2024-01-29 $17.96 $19.17 $17.81 $19.07 304 806
2024-01-26 $17.88 $18.18 $17.69 $17.89 240 250
2024-01-25 $17.28 $17.92 $17.00 $17.88 282 234
2024-01-24 $17.31 $17.43 $16.95 $16.99 346 716
2024-01-23 $17.19 $17.62 $16.82 $17.04 717 749
2024-01-22 $16.90 $17.27 $16.52 $17.13 656 743
2024-01-19 $17.22 $17.87 $16.95 $17.17 415 566
2024-01-18 $17.33 $17.45 $16.88 $17.18 461 433
Click to get the best stock tips daily for free!

About Verona Pharma plc

Verona Pharma plc Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the ... VRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT